Anaerobe
Autor: | Nagham Khanafer, Alain Gravet, Philippe Vanhems, Benoit Guery, Frédéric Barbut, David Boutoille, Anaelle Hemmendinger, Anne Vachee, Anne Marie Rogues, Dominique Vanjak |
---|---|
Přispěvatelé: | Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), ESCMID Study Group for Clostridioides Difficile (ESGCD), Université de Lausanne = University of Lausanne (UNIL), CHU Roubaix, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux [Bordeaux], Groupe hospitalier de la région de Mulhouse et Sud-Alsace, Centre d’Investigation Clinique de Nantes (CIC Nantes), Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre hospitalier universitaire de Nantes (CHU Nantes), Centre hospitalier universitaire de Nantes (CHU Nantes), Institut Curie [Paris], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Physiopathologie et Pharmacotoxicologie Placentaire Humaine (U1139), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Astellas Pharma |
Rok vydání: | 2020 |
Předmět: |
Point prevalence survey
Adult Male medicine.medical_specialty genetic structures Adolescent Microbiology European studies 03 medical and health sciences Young Adult Risk Factors Epidemiology Prevalence Medicine Humans Registries 030304 developmental biology Aged Aged 80 and over 0303 health sciences Surveillance 030306 microbiology business.industry Mortality rate Incidence (epidemiology) Incidence Gender distribution Middle Aged 3. Good health Europe Infectious Diseases Clostridioides difficile infection Population Surveillance Emergency medicine Epidemiological surveillance Clostridium Infections [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie Female France Symptom Assessment business Clostridioides |
Zdroj: | Anaerobe Anaerobe, 2021, 69, pp.102329. ⟨10.1016/j.anaerobe.2021.102329⟩ |
ISSN: | 1095-8274 1075-9964 |
Popis: | International audience; INTRODUCTION: The magnitude and scope of Clostridioides difficile infection (CDI) has changed with an increase in incidence and severity. The epidemiology of CDI is not well known in France due to difficulties to conduct large continuous surveillance. The objectives were to compare the characteristics of patients with CDI collected through repeated point prevalence survey via DIFTEC™, a free electronic tool, with those from previous French or European studies. METHODS: DIFTEC™ was developed to evaluate epidemiological burden, diagnostic strategies and management of CDI in France. National and European guidelines were used for definitions. A literature review of studies conducted in Western Europe on CDI and published between January, 2008 and May, 2018 was done to compare their data with those included in the DIFTEC™ database. RESULTS: From January 2016, to December 2017, 455 CDI episodes from 22 French hospitals were included. Most of CDI cases were health-care associated (HCA) (78%). The comparison between included patients and French literature data showed that the rates of previous antibiotics exposure, crude mortality and recurrence were not statistically different. However HCA-CDI was significantly more frequent in the DIFTEC™ study. Gender distribution, recurrence and crude mortality rates were not statistically different compared to European data. HCA-CDI was more frequent in the DIFTEC™ study whereas previous treatment with proton pump inhibitors and antibiotics were significantly higher in European studies. DISCUSSION: These results illustrated the added value of a new tool for increasing the reliable knowledge of CDI in France based on epidemiological surveillance implemented in health-care settings. |
Databáze: | OpenAIRE |
Externí odkaz: |